Atossa Beats Claims It Duped Investors In $4M Offering
A Washington federal court on Friday dismissed a proposed class action alleging breast cancer detection device maker Atossa Genetics Inc. misled investors into buying $3.7 million worth of shares in an...To view the full article, register now.
Already a subscriber? Click here to view full article